Quercetin up-regulates paraoxonase 1 gene expression via sterol regulatory element binding protein 2 that translocates from the endoplasmic reticulum to the nucleus where it specifically interacts with sterol responsive element-like sequence in paraoxonase 1 promoter in HuH7 liver cells

Metabolism: Clinical and Experimental

Volumn 59, Issue 9, 2010, Pages 1372-1378

  Garige, Mamatha ^a   Gong, Maokai ^a   Varatharajalu, Ravi ^a   Lakshman, M Raj ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; QUERCETIN; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; ARYLDIALKYLPHOSPHATASE;

ARTICLE; ATHEROGENESIS; CELL NUCLEUS; CELL STRAIN HUH7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOLOCALIZATION; LIVER CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; UPREGULATION; ANALYSIS OF VARIANCE; CELL CULTURE; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ARYLDIALKYLPHOSPHATASE; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MICROSCOPY, CONFOCAL; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROPHOTOMETRY; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 77956633911     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.025     Document Type: Article

References (23)

1. Aldridge W.N. Serum esterase II: an enzyme hydrolyzing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera Biochem. J 53 1953 117 124
2. Blatter M.C., James R.W., Messmer S., Barja F., and Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase Eur J Biochem 211 1993 871 879
3. Mackness M.I., Abbott C., Arrol S., and Durrington P.N. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation Biochem J 294 Pt 3 1993 829 834
4. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., and Fogelman A.M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
5. Rao M.N., Marmillot P., Gong M., Palmer D.A., Seeff L.B., and Strader D.B. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans Metabolism 52 2003 1287 1294
6. Aviram M., and Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development Free Radic Biol Med 37 2004 1304 1316
7. Mackness M.I., Arrol S., Abbott C.A., and Durrington P.N. Is paraoxonase related to atherosclerosis Chem Biol Interact 87 1993 161 171
8. Jakubowski H., Zhang L., Bardeguez A., and Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis Circ Res 87 2000 45 51
9. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., and Hama S. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 394 1998 284 287
10. Mackness M., Durrington P., and Mackness B. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease Curr Opin Lipidol 15 2004 399 404
11. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109 2002 1125 1131
12. Deakin S., Leviev I., Guernier S., and James R.W. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2 Arterioscler Thromb Vasc Biol 23 2003 2083 2089
13. Mullen E., Brown R.M., Osborne T.F., and Shay N.F. Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells J Nutr 134 2004 2942 2947
14. Gouedard C., Koum-Besson N., Barouki R., and Morel Y. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins Mol Pharmacol 63 2003 945 956
15. Gouedard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism Mol Cell Biol 24 2004 5209 5222
16. Khateeb J, Gantman A, Kreitenberg AJ, Aviram M, Fuhrman B. Paraoxonase 1 (PON1) expression is hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway.
17. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., and Coleman R. Reduced progression of atherosclerosis in apoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation Arterioscler Thromb Vasc Biol 17 1997 2744 2752
18. De Whalley C.V., Rankin S.M., Hoult J.R., Jessup W., and Leake D.S. Flavonoids inhibit the antioxidative modification of low density lipoproteins Biochem Pharmacol 39 1990 1743 1749
19. Hollman P.C., Hertgo M.G., and Katan M.B. Role of dietary flavonoids in protection against cancer and coronary heart disease Biochem Soc Trans 24 1996 785 789
20. Gong M., Garige M., Varatharajalu R., Marmillot P., Gottipatti C., and Leckey L.C. Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation Biochem Biophys Res Communication 379 2009 1001 1004
21. Humbert R., Adler D.A., and Disteche C.M. The molecular basis of the human serum paraoxonase activity polymorphism Nat Genet 3 1993 73 76
22. Garin M.C., James R.W., and Dussoix P. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes J Clin Invest 99 1997 62 66
23. Osaki F., Ikeda Y., Suehiro T., Ota K., Tsuzura S., and Arii K. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells Atherosclerosis 176 2004 279 287